57775-29-8CC(C)NCC(O)COc1cccc2[nH]c3ccccc3c12BQXQGZPYHWWCEB-UHFFFAOYSA-NCarazolol is a member of carbazoles.
57775-29-8DTXSID00866648CHEMBL324665CHEBI:135261165.5 Ų [M+H]+ [CCS Type: TW]
173.98 Ų [M-H]-
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Warning
H302 (97.5%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
Veterinary Drug -> beta-ADRENOCEPTOR_BLOCKING_AGENT -> -> JECFA Functional Classes
Pharmaceuticals -> Animal Drugs -> Approved in Taiwan
용도Carazolol is a promising high-affinity beta-adrenergic receptor ligand for the noninvasive determination of beta receptor status using PET
Yellowish solid